(BB) Société BIC - Overview
Stock: Stationery, Lighters, Shavers, Markers, Batteries
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 5.66% |
| Yield on Cost 5y | 8.15% |
| Yield CAGR 5y | 14.37% |
| Payout Consistency | 94.2% |
| Payout Ratio | 72.8% |
| Risk 5d forecast | |
|---|---|
| Volatility | 21.6% |
| Relative Tail Risk | -1.01% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.41 |
| Alpha | -14.65 |
| Character TTM | |
|---|---|
| Beta | 0.212 |
| Beta Downside | 0.664 |
| Drawdowns 3y | |
|---|---|
| Max DD | 27.92% |
| CAGR/Max DD | 0.08 |
Description: BB Société BIC January 13, 2026
Société BIC SA (ticker BB) is a French-based manufacturer of consumer stationery, personal-care, and ancillary products, selling a portfolio that includes BIC Cristal pens, Rocketbook smart notebooks, and BodyMark tattoo markers through mass-market retailers, office-supply channels and its own e-commerce site.
In FY 2023 the company generated roughly €2.2 billion of revenue, with an operating margin around 12 %-a level that reflects the high-volume, low-cost nature of its core pen business but also the premium contribution from growth-oriented lines such as smart reusable notebooks and eco-focused inks.
Key economic drivers for BIC include global consumer-discretionary spending trends, raw-material cost volatility (especially plastic resin and aluminum for pens and lighters), and the sustainability premium that is boosting demand for refillable and recyclable products. The stationery sector’s base growth rate is modest (≈2-3 % CAGR globally), but BIC’s “ECOlutions” and “Cristal Re’New” initiatives have positioned it to capture a larger share of the emerging “green” niche.
Assuming continued price stability for raw inputs and no major supply-chain disruptions, BIC’s earnings outlook remains tied to its ability to expand higher-margin categories (e.g., Rocketbook, BodyMark) while maintaining cost efficiencies in its legacy pen and lighter lines. A material shift in consumer preferences away from disposable writing tools would be a disconfirming factor that could materially impair the business model.
For a deeper, data-driven assessment of BIC’s valuation metrics and scenario analysis, you may find it useful to explore the company’s profile on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income: 288.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA -3.19 > 1.0 |
| NWC/Revenue: 24.84% < 20% (prev 26.08%; Δ -1.23% < -1%) |
| CFO/TA 0.12 > 3% & CFO 340.6m > Net Income 288.6m |
| Net Debt (54.8m) to EBITDA (575.6m): 0.10 < 3 |
| Current Ratio: 2.13 > 1.5 & < 3 |
| Outstanding Shares: last quarter (41.6m) vs 12m ago -1.54% < -2% |
| Gross Margin: 50.07% > 18% (prev 0.51%; Δ 4956 % > 0.5%) |
| Asset Turnover: 118.2% > 50% (prev 123.7%; Δ -5.56% > 0%) |
| Interest Coverage Ratio: 17.96 > 6 (EBITDA TTM 575.6m / Interest Expense TTM 22.9m) |
Altman Z'' 6.95
| A: 0.29 (Total Current Assets 1.50b - Total Current Liabilities 703.3m) / Total Assets 2.74b |
| B: 0.65 (Retained Earnings 1.77b / Total Assets 2.74b) |
| C: 0.15 (EBIT TTM 410.8m / Avg Total Assets 2.72b) |
| D: 1.82 (Book Value of Equity 1.93b / Total Liabilities 1.06b) |
| Altman-Z'' Score: 6.95 = AAA |
Beneish M -2.88
| DSRI: 1.08 (Receivables 584.5m/564.1m, Revenue 3.21b/3.34b) |
| GMI: 1.02 (GM 50.07% / 51.06%) |
| AQI: 1.19 (AQ_t 0.24 / AQ_t-1 0.20) |
| SGI: 0.96 (Revenue 3.21b / 3.34b) |
| TATA: -0.02 (NI 288.6m - CFO 340.6m) / TA 2.74b) |
| Beneish M-Score: -2.88 (Cap -4..+1) = A |
What is the price of BB shares?
Over the past week, the price has changed by +2.02%, over one month by +5.71%, over three months by +16.60% and over the past year by -6.49%.
Is BB a buy, sell or hold?
What are the forecasts/targets for the BB price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 57.4 | 3.5% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 59.3 | 6.8% |
BB Fundamental Data Overview February 03, 2026
P/E Trailing = 12.8369
P/E Forward = 11.976
P/S = 1.035
P/B = 1.3202
P/EG = 4.99
Revenue TTM = 3.21b EUR
EBIT TTM = 410.8m EUR
EBITDA TTM = 575.6m EUR
Long Term Debt = 120.0m EUR (from longTermDebt, last quarter)
Short Term Debt = 190.6m EUR (from shortTermDebt, last quarter)
Debt = 365.0m EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 54.8m EUR (from netDebt column, last quarter)
Enterprise Value = 2.26b EUR (2.21b + Debt 365.0m - CCE 310.1m)
Interest Coverage Ratio = 17.96 (Ebit TTM 410.8m / Interest Expense TTM 22.9m)
EV/FCF = 10.25x (Enterprise Value 2.26b / FCF TTM 220.8m)
FCF Yield = 9.76% (FCF TTM 220.8m / Enterprise Value 2.26b)
FCF Margin = 6.87% (FCF TTM 220.8m / Revenue TTM 3.21b)
Net Margin = 8.98% (Net Income TTM 288.6m / Revenue TTM 3.21b)
Gross Margin = 50.07% ((Revenue TTM 3.21b - Cost of Revenue TTM 1.60b) / Revenue TTM)
Gross Margin QoQ = 48.52% (prev 48.52%)
Tobins Q-Ratio = 0.83 (Enterprise Value 2.26b / Total Assets 2.74b)
Interest Expense / Debt = 4.33% (Interest Expense 15.8m / Debt 365.0m)
Taxrate = 31.57% (35.2m / 111.4m)
NOPAT = 281.1m (EBIT 410.8m * (1 - 31.57%))
Current Ratio = 2.13 (Total Current Assets 1.50b / Total Current Liabilities 703.3m)
Debt / Equity = 0.22 (Debt 365.0m / totalStockholderEquity, last quarter 1.68b)
Debt / EBITDA = 0.10 (Net Debt 54.8m / EBITDA 575.6m)
Debt / FCF = 0.25 (Net Debt 54.8m / FCF TTM 220.8m)
Total Stockholder Equity = 1.73b (last 4 quarters mean from totalStockholderEquity)
RoA = 10.62% (Net Income 288.6m / Total Assets 2.74b)
RoE = 16.70% (Net Income TTM 288.6m / Total Stockholder Equity 1.73b)
RoCE = 22.23% (EBIT 410.8m / Capital Employed (Equity 1.73b + L.T.Debt 120.0m))
RoIC = 13.94% (NOPAT 281.1m / Invested Capital 2.02b)
WACC = 6.16% (E(2.21b)/V(2.57b) * Re(6.69%) + D(365.0m)/V(2.57b) * Rd(4.33%) * (1-Tc(0.32)))
Discount Rate = 6.69% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -33.33 | Cagr: -1.68%
[DCF Debug] Terminal Value 85.65% ; FCFF base≈254.2m ; Y1≈264.0m ; Y5≈301.5m
Fair Price DCF = 201.1 (EV 8.24b - Net Debt 54.8m = Equity 8.18b / Shares 40.7m; r=6.16% [WACC]; 5y FCF grow 4.04% → 2.90% )
EPS Correlation: -34.43 | EPS CAGR: -38.95% | SUE: 0.0 | # QB: 0
Revenue Correlation: 60.36 | Revenue CAGR: 24.15% | SUE: 0.09 | # QB: 0
EPS next Year (2026-12-31): EPS=4.93 | Chg30d=+0.087 | Revisions Net=-1 | Growth EPS=+4.8% | Growth Revenue=-1.0%